京新药业：累计回购公司股份47271295股

Core Viewpoint - Jingxin Pharmaceutical (002020) announced a share buyback plan, intending to repurchase 47.271295 million shares, which represents 5.49% of the company's total share capital as of July 31, 2025 [1] Summary by Category - Company Announcement - Jingxin Pharmaceutical plans to repurchase shares through a dedicated securities account via centralized bidding [1] - The total number of shares to be repurchased is 47.271295 million [1] - This repurchase accounts for 5.49% of the company's current total share capital [1]